[VEGF in age-related macular degeneration. Part I. Physiologic and pathologic role of VEGF]
- PMID: 17687924
[VEGF in age-related macular degeneration. Part I. Physiologic and pathologic role of VEGF]
Abstract
VEGF, an endothelial specific growth factor, stimulates vascular permeability and angiogenesis. VEGF is involved in many physiological and pathological processes including embryogenesis, wound healing, tumor growth, choroidal neovascularization and many others. Authors discuss VEGF structure, known isoforms and their mechanisms of function, focusing on VEGF influence on eye tissues.
Similar articles
-
[VEGF, anti-vEGF and diseases].Bull Acad Natl Med. 2008 Feb;192(2):289-300; discussion 300-2. Bull Acad Natl Med. 2008. PMID: 18819684 Review. French.
-
Vascular endothelial growth factor biology: clinical implications for ocular treatments.Br J Ophthalmol. 2006 Dec;90(12):1542-7. doi: 10.1136/bjo.2006.098426. Br J Ophthalmol. 2006. PMID: 17114590 Free PMC article. Review.
-
Development and pathology of the hyaloid, choroidal and retinal vasculature.Int J Dev Biol. 2004;48(8-9):1045-58. doi: 10.1387/ijdb.041895ms. Int J Dev Biol. 2004. PMID: 15558494 Review.
-
Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.Curr Opin Ophthalmol. 2009 May;20(3):166-74. doi: 10.1097/ICU.0b013e328329d173. Curr Opin Ophthalmol. 2009. PMID: 19381089 Review.
-
VEGF in biological control.J Cell Biochem. 2007 Dec 15;102(6):1358-67. doi: 10.1002/jcb.21579. J Cell Biochem. 2007. PMID: 17979153 Review.
Cited by
-
The pathogenic role of the canonical Wnt pathway in age-related macular degeneration.Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4371-9. doi: 10.1167/iovs.09-4278. Epub 2009 Oct 29. Invest Ophthalmol Vis Sci. 2010. PMID: 19875668 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical